Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Transfusion Medicine (Oxford, England)|April 24, 2012
Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cellsK Gutensohn, A Nikolitsis, M Gramatzki, et al.
Transfusion|February 13, 2001
Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contaminationJ Riggert, A Humpe, T J Legler, et al.
Transfusion|November 14, 1997
Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapyA Humpe, J Riggert, K Vehmeyer, et al.
Bone Marrow Transplantation|July 6, 2006
Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantationA Pachnio, S Dietrich, W Klapper, et al.
Vox Sanguinis|March 27, 2009
Evidence for gene recombination in FCGR3 gene variantsK S Blum, Y Tong, R Siebert, et al.
British Journal of Haematology|August 1, 1995
Mobilization of CD34-positive tumour cells in a patient with testicular mixed germ cell tumourW Verbeek, A Pies, A Humpe, et al.
Transfusion|October 26, 1999
A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftmentA Humpe, J Riggert, U Munzel, et al.
Anticancer Research|August 15, 1998
Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancerB Wörmann, H Meden, J Riggert, et al.
Thrombosis and Haemostasis|December 29, 2000
Hepatitis C virus transmission through quarantine fresh-frozen plasmaA Humpe, T J Legler, C M Nübling, et al.
Transfusion|November 3, 2000
Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infectionT J Legler, J Riggert, G Simson, et al.
Pageof 3